PSYCHPHARM SEG 1: Biological Basis

Current Status

Not Enrolled

Price

CA$220.00

Get Started

Take this Course

The Psychopharmacology: Biological Basis course (15 hours or 1 credit) is an introduction to psychopharmacology. This segment is a starting point for students wishing to gain a deeper understanding of the basics of psychopharmacology, starting with the basic functions of the cell and nervous systems. This knowledge will act as a foundation for understanding the role of neurotransmitters in mental disorders.  Students will then learn the qualities and mechanics of drugs used to treat mental disorders as well as the impact these drugs have on the body. Finally, students will learn about drug non-adherence.

DBN Elite is approved by the Canadian Psychological Association to offer continuing education for psychologists. DBN Elite maintains responsibility for the program.

Download Pdf​
Learning Objectives

By the end of this course, students will achieve the following outcomes:

  1. Define the various structures of functions that make up the human nervous system at different levels.
  2. Identify the various qualities and mechanics of drugs commonly used in the treatment of psychiatric disorders.
  3. Recognize the major considerations associated with drug use and non-adherence.

The course lecture will be available online ​​DBN Elite. Students will be assessed twice throughout the course. They will be asked to complete a case study assignment and complete a final exam.

The course is pass/fail, no numeric grade will be provided.

  • Assignments (60%): You will be asked to submit an assignment after the lecture. Assignment instructions and rubric will be posted on the DBN Elite website.
  • Final Exam (40%): The course evaluation will be a cumulative exam that consists of 20 multiple-choice questions and true or false designed to assess your knowledge of psychopharmacology. The final exam will be available to you once you have completed the lecture.

Neurobiology

  • Human nervous system
  • Neuroanatomy and brain structures
  • Intracellular communication
  • Neurotransmitters

Pharmacology

  • Kinetic profile
  • Medication effects
  • Drug interactions

Diagnostic Considerations

  • State vs. trait variables
  • Personality disorders and primary disorders
  • Impact of substance abuse on diagnosis
  • Impact of physical illness on diagnosis

Medication Non-Adherence

Segment 1: Pre-recorded Q&A Exercise